The pharmaceutical industry produces a diverse array of products using a wide array of production methods, but this means that the industry also produces a wide array of waste streams. Clean-in-place (CIP) wastes contain active pharmaceutical ingredients, spent solvent wastes and bio solids. Some of these wastes can be treated by traditional wastewater treatment system, but others require incineration.
The pharmaceutical industry indeed faces significant challenges in managing its waste streams, and there are major challenges related to incineration:
- High Cost: Incineration is expensive, especially for waste streams with high water content.
- Government Restrictions: Governments are increasingly restricting incineration due to environmental concerns.
- State Tariffs: Many countries around the world have imposed tariffs on waste-to-incineration processes.
Therefore, finding cost-effective alternatives is essential.
The AquaCritox® SCWO process achieves the total destruction of API and spent solvent waste without the costly step of evaporating off water, leading to more sustainable and cost-effective pharmaceutical waste treatment. We continue seeking innovative solutions to protect our environment while meeting industry needs.
Please see our technologies and case studies below for more information, and don’t hesitate to contact us.
